In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Emerson Electric Co’s stock clocked out at $136.82, up 0.29% from its previous closing price of $136.43. In other words, the price has increased by $0.29 from its previous closing price. On the day, 3.15 million shares were traded. EMR stock price reached its highest trading level at $139.58 during the session, while it also had its lowest trading level at $134.72.
Ratios:
To gain a deeper understanding of EMR’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 34.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 28.09. For the most recent quarter (mrq), Quick Ratio is recorded 0.63 and its Current Ratio is at 0.85. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.44.
On August 07, 2025, Barclays Upgraded its rating to Equal Weight which previously was Underweight but kept the price unchanged to $127.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Train Michael H. sold 28,305 shares for $119.44 per share. The transaction valued at 3,380,749 led to the insider holds 232,669 shares of the business.
Train Michael H. bought 28,305 shares of EMR for $3,379,476 on May 12 ’25. On May 08 ’25, another insider, Karsanbhai Surendralal Lanca, who serves as the President & CEO of the company, sold 16,698 shares for $113.33 each. As a result, the insider received 1,892,384 and left with 164,957 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EMR now has a Market Capitalization of 77002301440 and an Enterprise Value of 89668296704. As of this moment, Emerson’s Price-to-Earnings (P/E) ratio for their current fiscal year is 29.39, and their Forward P/E ratio for the next fiscal year is 20.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.22. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.33 while its Price-to-Book (P/B) ratio in mrq is 3.88. Its current Enterprise Value per Revenue stands at 5.043 whereas that against EBITDA is 18.326.
Stock Price History:
The Beta on a monthly basis for EMR is 1.29, which has changed by 0.2614789 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, EMR has reached a high of $150.27, while it has fallen to a 52-week low of $90.06. The 50-Day Moving Average of the stock is 3.57%, while the 200-Day Moving Average is calculated to be 9.41%.
Shares Statistics:
It appears that EMR traded 3.05M shares on average per day over the past three months and 2189720 shares per day over the past ten days. A total of 562.80M shares are outstanding, with a floating share count of 561.45M. Insiders hold about 0.24% of the company’s shares, while institutions hold 82.80% stake in the company. Shares short for EMR as of 1760486400 were 15374163 with a Short Ratio of 5.04, compared to 1757894400 on 15967460. Therefore, it implies a Short% of Shares Outstanding of 15374163 and a Short% of Float of 2.74.
Dividends & Splits
With its trailing 12-month dividend rate of 2.108, EMR has a forward annual dividend rate of 2.11. Against a Trailing Annual Dividend Yield of 0.015451148. The stock’s 5-year Average Dividend Yield is 2.14. The current Payout Ratio is 61.25% for EMR, which recently paid a dividend on 2025-08-15 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 2006-12-12 when the company split stock in a 2:1 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 22.0 analysts currently analyzing and rating the stock of Emerson Electric Co (EMR).The consensus estimate for the next quarter is $1.5, with high estimates of $1.56 and low estimates of $1.43.
Analysts are recommending an EPS of between $6.04 and $5.97 for the fiscal current year, implying an average EPS of $6.0. EPS for the following year is $6.54, with 26.0 analysts recommending between $6.77 and $6.37.
Revenue Estimates
In. The current quarter, 18 analysts expect revenue to total $4.9B. It ranges from a high estimate of $4.95B to a low estimate of $4.85B. As of. The current estimate, Emerson Electric Co’s year-ago sales were $4.62BFor the next quarter, 18 analysts are estimating revenue of $4.44B. There is a high estimate of $4.53B for the next quarter, whereas the lowest estimate is $4.36B.
A total of 24 analysts have provided revenue estimates for EMR’s current fiscal year. The highest revenue estimate was $18.22B, while the lowest revenue estimate was $18.01B, resulting in an average revenue estimate of $18.07B. In the same quarter a year ago, actual revenue was $17.49BBased on 24 analysts’ estimates, the company’s revenue will be $19.07B in the next fiscal year. The high estimate is $19.43B and the low estimate is $18.58B.
